Piohope 15 Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Pioglitazone (15mg)
Overview Piohope 15 Tablet
Glycemia-15 tablets are prescribed for adult patients with type 2 diabetes. This medication assists in regulating blood glucose, mitigating the risk of serious diabetic complications such as visual impairment and nephropathy. Glycemia-15 can be administered independently or in conjunction with other therapies, with or without food. Consistent daily dosing at the same time maximizes efficacy. Dosage adjustments may occur based on individual response, as determined by your physician. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical guidance could lead to hyperglycemia and increased risk of kidney disease, blindness, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including a healthy diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects may include headache, sinusitis, myalgia, and pharyngitis. Report persistent or bothersome side effects to your doctor. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your doctor of any history of cardiovascular disease, thyroid disorders, or hormonal imbalances. Pregnancy or lactation necessitates consultation with your physician before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Piohope 15 Tablet
Managing type 2 diabetes
Major Benefits of Piohope 15 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Piohope 15 Tablet can be consumed with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Piohope 15 Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Piohope 15 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Piohope 15 Tablet can be consumed with or without food, though consistent timing is recommended.
How Piohope 15 Tablet works:
Glycemic control is achieved with Piohope 15 Tablet, an antidiabetic agent that enhances the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Piohope 15 Tablet is dangerous.
PregnancyCONSULT YOUR DOCTOR
The use of Piohope 15 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCAUTION
Use of Piohope 15 Tablet while breastfeeding requires careful consideration. Breastfeeding should be discontinued until maternal treatment concludes and the medication is fully cleared from the mother's system. Closely observe the infant's blood glucose levels throughout the mother's treatment with Piohope 15 Tablet.
DrivingSAFE
Driving ability is typically unaffected by Piohope 15 Tablet.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Piohope 15 Tablet without any necessary dosage modification.
LiverCAUTION
Patients with liver impairment should use Piohope 15 Tablet cautiously, potentially requiring dose modification under medical supervision. Piohope 15 Tablet is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Piohope 15 Tablet :
Omit any missed Piohope 15 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Piohope 15 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Thiazolidinedione-based compound |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | PPAR-gamma agonist (thiazolidinedione) |





